Analyst Ratings for Akebia Therapeutics (AKBA)
AKBA Rating Summary
AKBA Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $3.00 (Leerink)
- Average: $4.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$4.33 (+305%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
Rating Score: 6.8 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/4/2025 | H.C. Wainwright » Updated 4/6/2026 |
Matthew Caufield | New Coverage | Buy (N/A) |
6.00 (N/A) |
3.42 (1.07) |
-68.71% | Details |
| 4/28/2025 | Leerink » Updated 4/14/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
3.00 (N/A) |
2.38 (1.07) |
-55.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
